March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Effect Of Melatonin On Prednisolone Eye Disposition In Cats
Author Affiliations & Notes
  • Maria J. Del Sole
    Fisiopatologia, Facultad Ciencias Veterinarias, UNCPBA, Tandil, Argentina
  • Paula Schaiquevich
    Unit of Clinical Pharmacokinetics, CONICET-Hosp de Ped JP Garrahan, Ciudad de Buenos Aires, Argentina
  • Marcelo A. Aba
    Fisiopatologia, Facultad Ciencias Veterinarias, UNCPBA, Tandil, Argentina
  • Carlos E. Lanusse
    Fisiopatologia, Facultad Ciencias Veterinarias, UNCPBA, Tandil, Argentina
  • Laura Moreno
    Fisiopatologia, Facultad Ciencias Veterinarias, UNCPBA, Tandil, Argentina
  • Footnotes
    Commercial Relationships  Maria J. Del Sole, None; Paula Schaiquevich, None; Marcelo A. Aba, None; Carlos E. Lanusse, None; Laura Moreno, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 462. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria J. Del Sole, Paula Schaiquevich, Marcelo A. Aba, Carlos E. Lanusse, Laura Moreno; Effect Of Melatonin On Prednisolone Eye Disposition In Cats. Invest. Ophthalmol. Vis. Sci. 2012;53(14):462.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To characterize prednisolone (PRED) ocular and systemic pharmacokinetics in cats after oral administration and to study the effect of concomitant administration of melatonin (MEL) on PRED disposition.

 
Methods:
 

Six (6) castrated young physically and ophthalmologically healthy male European Short Hair cats were orally administrated with a single dose (10 mg) of PRED or a single dose of PRED (10 mg) and MEL (3 mg) in tablet. In anesthetized cats 2 mL of blood and 450 µL of aqueous humor (AH) were obtained from preplaced cephalic antebrachial intravenous catheters and from one eye by direct puncture, respectively, at: 0.25, 0.5, 1, 1.5, 2, 3, 4 and 5 h after administration. Plasma and AH samples were assayed for PRED by HPLC. A two-compartment model was used to simultaneously fit PRED plasma and aqueous concentration vs. time data using ADAPT 5. The estimated pharmacokinetic (PK) parameters included the absorption rate constant (ka), elimination rate constant from the central compartment (kc), intercompartment rate constants between plasma and aqueous humor (kpa), apparent volume of distribution of the central compartment (Vc/F). PK parameters were compared between groups (PRED vs. PRED+MEL) by means of Wilcoxon matched pairs test (p<0.05).

 
Results:
 

The model adequately fitted the data and the estimated median (interval) PK parameters are shown in Table 1. No significant difference was observed in the PK parameters when comparing between groups of treatments (p>0.05).

 
Conclusions:
 

These results indicated that MEL does not modify PRED systemic or ocular disposition in cats when both are administrated simultaneously. A possible synergic pharmacological effect may be account for different mechanisms of action, but not for pharmacokinetic synergism and will be further studied.  

 
Keywords: corticosteroids • melatonin • antioxidants 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×